Global Contract Research Organisations (CROs) 麻豆原创 Research Report 2024

Publication ID:

PB506241944

Publication Date:

June 19, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

A听contract research organization听(CRO) is a company that provides support to the听pharmaceutical,听biotechnology, and听medical device听industries in the form of research services听outsourced听on a contract basis. A CRO may provide such services as biopharmaceutical development,听biologic assay听development, commercialization,听preclinical research,听clinical research,听clinical trials听management, and听pharmacovigilance.
The global Contract Research Organisations (CROs) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Contract Research Organisations (CROs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Contract Research Organisations (CROs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Contract Research Organisations (CROs) in Pharmaceutical & Biotechnological Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Contract Research Organisations (CROs) include IQVIA, Labcorp, PAREXEL, Pharmaceutical Product Development, INC RESEARCH HOLDINGS, PRA Health Sciences, ICON, Charles River and Advent International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Contract Research Organisations (CROs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Research Organisations (CROs).
Report Scope
The Contract Research Organisations (CROs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contract Research Organisations (CROs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Research Organisations (CROs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
IQVIA
Labcorp
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Segment by Type
Preclinical CROs
Clinical CROs
Segment by Application
Pharmaceutical & Biotechnological Companies
Medical Device Companies
Academic & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Research Organisations (CROs) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Contract Research Organisations (CROs) 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical CROs
1.2.3 Clinical CROs
1.3 麻豆原创 by Application
1.3.1 Global Contract Research Organisations (CROs) 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnological Companies
1.3.3 Medical Device Companies
1.3.4 Academic & Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contract Research Organisations (CROs) 麻豆原创 Perspective (2019-2030)
2.2 Contract Research Organisations (CROs) Growth Trends by Region
2.2.1 Global Contract Research Organisations (CROs) 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Contract Research Organisations (CROs) Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Contract Research Organisations (CROs) Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Contract Research Organisations (CROs) 麻豆原创 Dynamics
2.3.1 Contract Research Organisations (CROs) Industry Trends
2.3.2 Contract Research Organisations (CROs) 麻豆原创 Drivers
2.3.3 Contract Research Organisations (CROs) 麻豆原创 Challenges
2.3.4 Contract Research Organisations (CROs) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Contract Research Organisations (CROs) Players by Revenue
3.1.1 Global Top Contract Research Organisations (CROs) Players by Revenue (2019-2024)
3.1.2 Global Contract Research Organisations (CROs) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Contract Research Organisations (CROs) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Contract Research Organisations (CROs) Revenue
3.4 Global Contract Research Organisations (CROs) 麻豆原创 Concentration Ratio
3.4.1 Global Contract Research Organisations (CROs) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Research Organisations (CROs) Revenue in 2023
3.5 Contract Research Organisations (CROs) Key Players Head office and Area Served
3.6 Key Players Contract Research Organisations (CROs) Product Solution and Service
3.7 Date of Enter into Contract Research Organisations (CROs) 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Contract Research Organisations (CROs) Breakdown Data by Type
4.1 Global Contract Research Organisations (CROs) Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Contract Research Organisations (CROs) Forecasted 麻豆原创 Size by Type (2025-2030)
5 Contract Research Organisations (CROs) Breakdown Data by Application
5.1 Global Contract Research Organisations (CROs) Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Contract Research Organisations (CROs) Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Contract Research Organisations (CROs) 麻豆原创 Size (2019-2030)
6.2 North America Contract Research Organisations (CROs) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Contract Research Organisations (CROs) 麻豆原创 Size by Country (2019-2024)
6.4 North America Contract Research Organisations (CROs) 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Contract Research Organisations (CROs) 麻豆原创 Size (2019-2030)
7.2 Europe Contract Research Organisations (CROs) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Contract Research Organisations (CROs) 麻豆原创 Size by Country (2019-2024)
7.4 Europe Contract Research Organisations (CROs) 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Contract Research Organisations (CROs) 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Contract Research Organisations (CROs) 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Contract Research Organisations (CROs) 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Contract Research Organisations (CROs) 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Contract Research Organisations (CROs) 麻豆原创 Size (2019-2030)
9.2 Latin America Contract Research Organisations (CROs) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Contract Research Organisations (CROs) 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Contract Research Organisations (CROs) 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Contract Research Organisations (CROs) 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Contract Research Organisations (CROs) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Contract Research Organisations (CROs) 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Contract Research Organisations (CROs) 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Detail
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Contract Research Organisations (CROs) Introduction
11.1.4 IQVIA Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.1.5 IQVIA Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Contract Research Organisations (CROs) Introduction
11.2.4 Labcorp Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.2.5 Labcorp Recent Development
11.3 PAREXEL
11.3.1 PAREXEL Company Detail
11.3.2 PAREXEL Business Overview
11.3.3 PAREXEL Contract Research Organisations (CROs) Introduction
11.3.4 PAREXEL Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.3.5 PAREXEL Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Detail
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Contract Research Organisations (CROs) Introduction
11.4.4 Pharmaceutical Product Development Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 INC RESEARCH HOLDINGS
11.5.1 INC RESEARCH HOLDINGS Company Detail
11.5.2 INC RESEARCH HOLDINGS Business Overview
11.5.3 INC RESEARCH HOLDINGS Contract Research Organisations (CROs) Introduction
11.5.4 INC RESEARCH HOLDINGS Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.5.5 INC RESEARCH HOLDINGS Recent Development
11.6 PRA Health Sciences
11.6.1 PRA Health Sciences Company Detail
11.6.2 PRA Health Sciences Business Overview
11.6.3 PRA Health Sciences Contract Research Organisations (CROs) Introduction
11.6.4 PRA Health Sciences Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.6.5 PRA Health Sciences Recent Development
11.7 ICON
11.7.1 ICON Company Detail
11.7.2 ICON Business Overview
11.7.3 ICON Contract Research Organisations (CROs) Introduction
11.7.4 ICON Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.7.5 ICON Recent Development
11.8 Charles River
11.8.1 Charles River Company Detail
11.8.2 Charles River Business Overview
11.8.3 Charles River Contract Research Organisations (CROs) Introduction
11.8.4 Charles River Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.8.5 Charles River Recent Development
11.9 Advent International
11.9.1 Advent International Company Detail
11.9.2 Advent International Business Overview
11.9.3 Advent International Contract Research Organisations (CROs) Introduction
11.9.4 Advent International Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.9.5 Advent International Recent Development
11.10 WuXi AppTec, Inc.
11.10.1 WuXi AppTec, Inc. Company Detail
11.10.2 WuXi AppTec, Inc. Business Overview
11.10.3 WuXi AppTec, Inc. Contract Research Organisations (CROs) Introduction
11.10.4 WuXi AppTec, Inc. Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.10.5 WuXi AppTec, Inc. Recent Development
11.11 Pharmaron Beijing Co., Ltd.
11.11.1 Pharmaron Beijing Co., Ltd. Company Detail
11.11.2 Pharmaron Beijing Co., Ltd. Business Overview
11.11.3 Pharmaron Beijing Co., Ltd. Contract Research Organisations (CROs) Introduction
11.11.4 Pharmaron Beijing Co., Ltd. Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.11.5 Pharmaron Beijing Co., Ltd. Recent Development
11.12 Hangzhou Tigermed Consulting Co.,Ltd.
11.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Detail
11.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
11.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Contract Research Organisations (CROs) Introduction
11.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
11.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Detail
11.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
11.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Contract Research Organisations (CROs) Introduction
11.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Contract Research Organisations (CROs) Business (2019-2024)
11.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

IQVIA
Labcorp
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.